HINGHAM, MA – Microbot Medical Inc. (NASDAQ:MBOT), a clinical-stage medical device company with a market capitalization of $43.2 million, announced significant developments, including fundraising ...

Roth Capital analyst Kyle Bauser initiated coverage of Microbot Medical (MBOT) with a Buy rating and $5.50 price target The firm says the company’s Liberty Endovascular Robotic System achieved FDA ...

Your browser does not support iframes. Our coverage area is an unusual geographic market: the Lehigh Valley and Berks County. It's the third largest business district ...

For immediate concerns about closed captioning of broadcast programs or online video content during weekday business hours 8 a.m.-5 p.m., call David Harpe at (303) 830-6426 or e-mail ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Situated within the McCormick School of Engineering and driven by the CS+X initiative, the Department of Computer Science (CS) at Northwestern University prepares students to perform impactful and ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Mbot 3D belongs to MagicFirm, which was founded in 2009. It is the first 3D printing service provider in China. MagicFirm is committed to providing integrated solutions for architectural design, ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...